Etcembly
PrivateLast Round
Series A
Extension
Dec 8, 2023
Est. Valuation
$29.9M
Total Funding Raised
$12.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Etcembly is a biotechnology company that utilizes a proprietary generative AI platform, EMLy™, to discover and engineer T-cell receptor (TCR) immunotherapies for cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, ML Platforms, Precision Medicine
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Etcembly Comparables
Compare Etcembly with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Exogene | 87% | |
| Engimmune Therapeutics | 83% | |
| T-Cypher Bio | 77% | |
Etcembly Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Dec 8, 2023 | ||||
| Series A | Dec 14, 2022 | ||||
| Seed | Apr 23, 2021 |
Key People
Founding team and executive leadership
Etcembly Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| iGlobe Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 178% MoM, reaching 4.4K.
- Mar 18, 2026
Collaboration with Avigen Ltd. has been a resounding success.
Etcembly Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Etcembly's valuation, stock price, and market status.